Soleno Therapeutics, Inc. · NASDAQ:SLNO

Nantahala Capital Management, LLC reported a 5.60% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 30, 2025

Nantahala Capital Management, LLC reported a 5.60% stake in Soleno Therapeutics, Inc., 2,627,651 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).

Stake
5.60%
Shares
2,627,651
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC5.60%2,627,651
Wilmot B. Harkey5.60%2,627,651
Daniel Mack5.60%2,627,651

Source

View original at SEC

Related